Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Medplus Health Services's EV-to-OCF or its related term are showing as below:
NSE:MEDPLUS'
s EV-to-OCF Range Over the Past 10 Years
Min: 17.68 Med: 0 Max: 17.68
Current: 17.68
During the past 8 years, the highest EV-to-OCF of Medplus Health Services was 17.68. The lowest was 17.68. And the median was .
NSE:MEDPLUS's EV-to-OCF is ranked worse than 75.62% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 8.83
vs NSE:MEDPLUS: 17.68
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medplus Health Services (NSE:MEDPLUS) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medplus Health Services's PE Ratio (TTM) for today is calculated as:
Medplus Health Services's share price for today is ₹659.65.
Medplus Health Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17.525.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medplus Health Services EV-to-OCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, Medplus Health Services's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medplus Health Services EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medplus Health Services's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Medplus Health Services's EV-to-OCF falls into.
Medplus Health Services's current Enterprise Value is ₹87,510 Mil.
Medplus Health Services's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹ Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?
Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued.
The current stock price of ₹659.65 is trading 32.7% below its estimated GF Value™ of ₹980.39.
GuruFocus considers Medplus Health Services to be Significantly Undervalued.
Key valuation signals for NSE:MEDPLUS:
EV-to-OCF:
GF Value™: ₹980.39 vs. price of ₹659.65 (32.7% below fair value)
No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
81GF Score
Get the complete analysis for NSE:MEDPLUS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDPLUS has been successfully added to your 
